Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

Friday, May 26, 2023 1 min read

Key Takeaway: Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

Full Press Release Details

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure.